loadpatents
name:-0.024982929229736
name:-0.02212381362915
name:-0.013066053390503
Peixoto; Christophe Patent Filings

Peixoto; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Peixoto; Christophe.The latest application filed is for "5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis".

Company Profile
12.16.20
  • Peixoto; Christophe - Romainville FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds and pharmaceutical compositions thereof for the treatment of diseases
Grant 11,339,166 - Alvey , et al. May 24, 2
2022-05-24
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione Derivatives As Adamts Inhibitors For The Treatment Of Osteoarthritis
App 20210309614 - BREBION; Franck Laurent ;   et al.
2021-10-07
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Grant 11,072,611 - Desroy , et al. July 27, 2
2021-07-27
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Diseases
App 20210101903 - ALVEY; Luke Jonathan ;   et al.
2021-04-08
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
Grant 10,941,117 - Brebion , et al. March 9, 2
2021-03-09
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis
Grant 10,829,478 - Labeguere , et al. November 10, 2
2020-11-10
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20200239466 - DESROY; Nicolas ;   et al.
2020-07-30
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione Derivatives As Adamts Inhibitors For The Treatment Of Osteoarthritis
App 20200216397 - BREBION; Franck Laurent ;   et al.
2020-07-09
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis
Grant 10,550,100 - Labeguere , et al. Fe
2020-02-04
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Grant 10,526,329 - Desroy , et al. J
2020-01-07
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
Grant 10,487,060 - Brebion , et al. Nov
2019-11-26
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione Derivatives As Adamts 4 And 5 Inhibitors For Treating E.g. Osteoarth
App 20190315719 - LABEGU RE; Frederic Gilbert ;   et al.
2019-10-17
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione Derivatives As Adamts 4 And 5 Inhibitors For Treating E.g. Osteoarth
App 20190300503 - LABEGU RE; Frederic Gilbert ;   et al.
2019-10-03
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20190169184 - DESROY; Nicolas ;   et al.
2019-06-06
Methods For Treatment Of Muscular Dystrophies
App 20190167640 - Bush; Ernest D. ;   et al.
2019-06-06
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Grant 10,125,132 - Desroy , et al. November 13, 2
2018-11-13
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione Derivatives As Adamts Inhibitors For The Treatment Of Osteoarthritis
App 20180258052 - BREBION; Franck Laurent ;   et al.
2018-09-13
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20180127425 - DESROY; Nicolas ;   et al.
2018-05-10
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
Grant 9,926,281 - Brebion , et al. March 27, 2
2018-03-27
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione Derivatives As Adamts Inhibitors For The Treatment Of Osteoarthritis
App 20180002293 - BREBION; Franck Laurent ;   et al.
2018-01-04
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20170362227 - DESROY; Nicolas ;   et al.
2017-12-21
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Grant 9,796,719 - Desroy , et al. October 24, 2
2017-10-24
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Grant 9,670,204 - Desroy , et al. June 6, 2
2017-06-06
Methods For Treatment Of Muscular Dystrophies
App 20160250188 - Bush; Ernest D. ;   et al.
2016-09-01
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20160244443 - DESROY; Nicolas ;   et al.
2016-08-25
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20160214986 - DESROY; Nicolas ;   et al.
2016-07-28
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Grant 9,249,141 - Desroy , et al. February 2, 2
2016-02-02
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20150111872 - DESROY; Nicolas ;   et al.
2015-04-23
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
Grant 8,993,590 - Desroy , et al. March 31, 2
2015-03-31
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Inflammatory Disorders
App 20140303140 - DESROY; Nicolas ;   et al.
2014-10-09
Imidazolidine compounds as androgen receptor modulators
Grant 8,383,608 - Nique , et al. February 26, 2
2013-02-26
Novel Imidazolidine Compounds As Androgen Receptor Modulators
App 20120178718 - Nique; Francois ;   et al.
2012-07-12
Imidazolidine compounds as androgen receptor modulators
Grant 7,968,581 - Nique , et al. June 28, 2
2011-06-28
Novel Imidazolidine Compounds As Androgen Receptor Modulators
App 20100113547 - Nique; Francois ;   et al.
2010-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed